Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases

by Mariam Lotfy Khaled, Ahmad A. Tarhini, Peter A. Forsyth, Inna Smalley, Yolanda Piña
Published 2023-03-01

Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma

by Daniel J. Glazar, G. Daniel Grass, John A. Arrington, Peter A. Forsyth, Natarajan Raghunand, Hsiang-Hsuan Michael Yu, Solmaz Sahebjam, Heiko Enderling
Published 2020-06-01

Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.

by Franz J Zemp, Brienne A McKenzie, Xueqing Lun, Lori Maxwell, Karlyne M Reilly, Grant McFadden, V Wee Yong, Peter A Forsyth
Published 2013-01-01

Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models

by Paulo C Rodriguez, Zhihua Chen, Y Ann Chen, Lilit Karapetyan, Jiannong Li, Manali S Phadke, Jessica K Mandula, Peter A Forsyth, Keiran S M Smalley
Published 2023-12-01

Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies

by Sebastian Rubino, Daniel E. Oliver, Nam D. Tran, Michael A. Vogelbaum, Peter A. Forsyth, Hsiang-Hsuan Michael Yu, Kamran Ahmed, Arnold B. Etame
Published 2022-03-01

Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

by Henry Ogbomo, Franz J Zemp, Xueqing Lun, Jiqing Zhang, Danuta Stack, Masmudur M Rahman, Grant McFadden, Christopher H Mody, Peter A Forsyth
Published 2013-01-01

Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor.

by LiMei Wang, Jennifer J Rahn, XueQing Lun, Beichen Sun, John J P Kelly, Samuel Weiss, Stephen M Robbins, Peter A Forsyth, Donna L Senger
Published 2008-11-01

Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With V600E-Mutated Gliomas

by Michael J. Fusco PharmD, Yolanda Piña MD, Robert J. Macaulay MD, Solmaz Sahebjam MD, Peter A. Forsyth MD, Edwin Peguero MD, Christine M. Walko PharmD
Published 2021-09-01

The p75 neurotrophin receptor is a central regulator of glioma invasion.

by Angela L M Johnston, Xueqing Lun, Jennifer J Rahn, Abdelhamid Liacini, Limei Wang, Mark G Hamilton, Ian F Parney, Barbara L Hempstead, Stephen M Robbins, Peter A Forsyth, Donna L Senger
Published 2007-08-01

HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis

by Michael F. Emmons, Richard L. Bennett, Alberto Riva, Kanchan Gupta, Larissa Anastasio Da Costa Carvalho, Chao Zhang, Robert Macaulay, Daphne Dupéré-Richér, Bin Fang, Edward Seto, John M. Koomen, Jiannong Li, Y. Ann Chen, Peter A. Forsyth, Jonathan D. Licht, Keiran S. M. Smalley
Published 2023-11-01

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma

by Shawn T. Beug, Caroline E. Beauregard, Cristin Healy, Tarun Sanda, Martine St-Jean, Janelle Chabot, Danielle E. Walker, Aditya Mohan, Nathalie Earl, Xueqing Lun, Donna L. Senger, Stephen M. Robbins, Peter Staeheli, Peter A. Forsyth, Tommy Alain, Eric C. LaCasse, Robert G. Korneluk
Published 2017-02-01

Correction: Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma

by Shawn T. Beug, Caroline E. Beauregard, Cristin Healy, Tarun Sanda, Martine St-Jean, Janelle Chabot, Danielle E. Walker, Aditya Mohan, Nathalie Earl, Xueqing Lun, Donna L. Senger, Stephen M. Robbins, Peter Staeheli, Peter A. Forsyth, Tommy Alain, Eric C. LaCasse, Robert G. Korneluk
Published 2018-07-01

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

by Matthew N. Mills, Chelsea Walker, Chetna Thawani, Afrin Naz, Nicholas B. Figura, Sergiy Kushchayev, Arnold Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed
Published 2021-03-01

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

by Matthew N. Mills, Afrin Naz, Chetna Thawani, Chelsea Walker, Nicholas B. Figura, Sergiy Kushchayev, Daniel E. Oliver, Arnold B. Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James K. C. Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed
Published 2021-05-01

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study

by Kamran A. Ahmed, MD, Youngchul Kim, PhD, John A. Arrington, MD, Sungjune Kim, MD, PhD, Michelle DeJesus, BS, Aixa E. Soyano, MD, Avan J. Armaghani, MD, Ricardo L.B. Costa, MD, Hung T. Khong, MD, Loretta S. Loftus, MD, Marilin Rosa, MD, Jimmy J. Caudell, MD, PhD, Roberto Diaz, MD, PhD, Timothy J. Robinson, MD, PhD, Arnold B. Etame, MD, PhD, Nam D. Tran, MD, PhD, Solmaz Sahebjam, MD, Hatem H. Soliman, MD, Brian J. Czerniecki, MD, PhD, Peter A. Forsyth, MD, H. Michael Yu, MD, Hyo S. Han, MD
Published 2021-11-01